These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 34774561)
1. Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1. Hong Q; Cai H; Zhang L; Li Z; Zhong F; Ni Z; Cai G; Chen XM; He JC; Lee K Kidney Int; 2022 Feb; 101(2):299-314. PubMed ID: 34774561 [TBL] [Abstract][Full Text] [Related]
2. LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease. Wang X; Sun Z; Fu J; Fang Z; Zhang W; He JC; Lee K Mol Ther; 2024 Sep; 32(9):3177-3193. PubMed ID: 38910328 [TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Yeh YC; Wei WC; Wang YK; Lin SC; Sung JM; Tang MJ Am J Pathol; 2010 Oct; 177(4):1743-54. PubMed ID: 20709799 [TBL] [Abstract][Full Text] [Related]
5. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF- Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225 [TBL] [Abstract][Full Text] [Related]
6. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling. He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960 [TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor. Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746 [TBL] [Abstract][Full Text] [Related]
9. Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis. Wei X; Xia Y; Li F; Tang Y; Nie J; Liu Y; Zhou Z; Zhang H; Hou FF J Am Soc Nephrol; 2013 Sep; 24(9):1387-98. PubMed ID: 23723426 [TBL] [Abstract][Full Text] [Related]
10. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling. Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895 [TBL] [Abstract][Full Text] [Related]
11. Tubular cell transcriptional intermediary factor 1γ deficiency exacerbates kidney injury-induced tubular cell polyploidy and fibrosis. Yuan C; Jin G; Li P; Wang W; Ge C; Pan Y; Zhang Q; Mo J; Kuang D; Liu L; Zhang X; Liang H; Zhang W; Tang X; Li Z; Liu J; Xu G; Chen X; Ding ZY; Zhang B Kidney Int; 2023 Oct; 104(4):769-786. PubMed ID: 37482091 [TBL] [Abstract][Full Text] [Related]
12. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy. Li L; Emmett N; Mann D; Zhao X Exp Biol Med (Maywood); 2010 Mar; 235(3):383-91. PubMed ID: 20404057 [TBL] [Abstract][Full Text] [Related]
13. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway. Zhang W; Rong G; Gu J; Fan C; Guo T; Jiang T; Deng W; Xie J; Su Z; Yu Q; Mai J; Zheng R; Chen X; Tang X; Zhang J FASEB J; 2022 Mar; 36(3):e22084. PubMed ID: 35107844 [TBL] [Abstract][Full Text] [Related]
15. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro. Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171 [TBL] [Abstract][Full Text] [Related]
16. LRG1 Promotes ECM Integrity by Activating the TGF-β Signaling Pathway in Fibroblasts. Park HN; Song MJ; Choi YE; Lee DH; Chung JH; Lee ST Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569820 [TBL] [Abstract][Full Text] [Related]
17. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059 [TBL] [Abstract][Full Text] [Related]
18. Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis. Liu C; Lim ST; Teo MHY; Tan MSY; Kulkarni MD; Qiu B; Li A; Lal S; Dos Remedios CG; Tan NS; Wahli W; Ferenczi MA; Song W; Hong W; Wang X Circ Heart Fail; 2019 Dec; 12(12):e005962. PubMed ID: 31830829 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA Wang P; Luo ML; Song E; Zhou Z; Ma T; Wang J; Jia N; Wang G; Nie S; Liu Y; Hou F Sci Transl Med; 2018 Oct; 10(462):. PubMed ID: 30305452 [TBL] [Abstract][Full Text] [Related]
20. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo. Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]